Medivation, Inc. Announces Participation At Upcoming Investor Conference
Published: Jan 07, 2014
SAN FRANCISCO, CA--(Marketwired - January 06, 2014) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:
- David Hung, M.D., president and chief executive officer, will present at the 32nd Annual J. P. Morgan Healthcare Conference on Monday, January 13 at 4:30pm PT at the Westin St. Francis Hotel in San Francisco, CA.
Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm. A replay of the webcast will be available on the Company's website for 30 days following the live event.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.
Chief Business & Financial Officer
Sr. Director, Investor Relations
Help employers find you! Check out all the jobs and post your resume.